Reviews Etanercept


No reviews yet.

Enbrel Drug Description
Enbrel
(etanercept) Solution for Subcutaneous Use

WARNINGS
SERIOUS INFECTIONS AND MALIGNANCIES
SERIOUS INFECTIONS
Patients treated with Enbrel are at increased risk for developing serious infections
that may lead to hospitalization or death [see WARNINGS AND PRECAUTIONS and
ADVERSE REACTIONS]. Most patients who developed these infections were taking
concomitant immunosuppressants such as methotrexate or corticosteroids.
Enbrel should be discontinued if a patient develops a serious infection or
sepsis.
Reported infections include:

Active tuberculosis, including reactivation of latent tuberculosis. Patients
with tuberculosis have frequently presented with disseminated or extrapulmonary
disease. Patients should be tested for latent tuberculosis before Enbrel use
and during therapy. Treatment for latent infection should be initiated prior
to Enbrel use.
Invasive fungal infections, including histoplasmosis, coccidioidomycosis,
candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with
histoplasmosis or other invasive fungal infections may present with disseminated,
rather than localized, disease. Antigen and antibody testing for histoplasmosis
may be negative in some patients with active infection. Empiric anti-fungal
therapy should be considered in patients at risk for invasive fungal infections
who develop severe systemic illness.
Bacterial, viral, and other infections due to opportunistic pathogens.

The risks and benefits of treatment with Enbrel should be carefully considered
prior to initiating therapy in patients with chronic or recurrent infection.
Patients should be closely monitored for the development of signs and symptoms
of infection during and after treatment with Enbrel, including the possible
development of tuberculosis in patients who tested negative for latent tuberculosis
infection prior to initiating therapy.
MALIGNANCIES
Lymphoma and other malignancies, some fatal, have been reported in children
and adolescent patients treated with TNF blockers, including Enbrel.

DRUG DESCRIPTION



What are the possible side effects of etanercept (Enbrel, Enbrel SureClick)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Serious and sometimes fatal infections may occur during treatment with etanercept. Stop using etanercept and call your doctor right away if you have signs of infection such as:

fever, sweating, chills, tired feeling;
feeling short of breath;
cough, sore throat; or
flu symptoms,...
Read All Potential Side Effects for Enbrel »




Enbrel (etanercept) is a dimeric fusion protein consisting of the extracellular
ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor
receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of
etanercept contains the CH2 domain, the CH3 domain and
hinge region, but not the CH1 domain of IgG1. Etanercept is produced
by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell
expression system. It consists of 934 amino acids and has an apparent molecular
weight of approximately 150 kilodaltons.
The solution of Enbrel in the single-use prefilled syringe and the single-use
prefilled SureClick autoinjector is clear and colorless, sterile, preservative-free,
and is formulated at pH 6.3 ± 0.2.
Enbrel is also supplied in a multiple-use vial as a sterile, white, preservative-free,
lyophilized powder. Reconstitution with 1 mL of the supplied Sterile Bacteriostatic
Water for Injection, USP (containing 0.9% benzyl alcohol) yields a multiple-use,
clear, and colorless solution with a pH of 7.4 ± 0.3.
Table 5: Contents of Enbrel



Presentation
Active Ingredient Content
Inactive Ingredients Content


Enbrel 50 mg prefilled syringe and SureClick autoinjector
0.98 mL of a 50 mg/mL solution of etanercept

1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate



Enbrel 25 mg prefilled syringe
0.51 mL of a 50 mg/mL solution of etanercept
1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate


Enbrel 25 mg multiple-usevial
25 mg etanercept
40 mg mannitol
10 mg sucrose
1.2 mg tromethamine



Last reviewed on RxList: 8/30/2010




Enbrel Drug Description
Enbrel
(etanercept) Solution for Subcutaneous Use

WARNINGS
SERIOUS INFECTIONS AND MALIGNANCIES
SERIOUS INFECTIONS
Patients treated with Enbrel are at increased risk for developing serious infections
that may lead to hospitalization or death [see WARNINGS AND PRECAUTIONS and
ADVERSE REACTIONS]. Most patients who developed these infections were taking
concomitant immunosuppressants such as methotrexate or corticosteroids.
Enbrel should be discontinued if a patient develops a serious infection or
sepsis.
Reported infections include:

Active tuberculosis, including reactivation of latent tuberculosis. Patients
with tuberculosis have frequently presented with disseminated or extrapulmonary
disease. Patients should be tested for latent tuberculosis before Enbrel use
and during therapy. Treatment for latent infection should be initiated prior
to Enbrel use.
Invasive fungal infections, including histoplasmosis, coccidioidomycosis,
candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with
histoplasmosis or other invasive fungal infections may present with disseminated,
rather than localized, disease. Antigen and antibody testing for histoplasmosis
may be negative in some patients with active infection. Empiric anti-fungal
therapy should be considered in patients at risk for invasive fungal infections
who develop severe systemic illness.
Bacterial, viral, and other infections due to opportunistic pathogens.

The risks and benefits of treatment with Enbrel should be carefully considered
prior to initiating therapy in patients with chronic or recurrent infection.
Patients should be closely monitored for the development of signs and symptoms
of infection during and after treatment with Enbrel, including the possible
development of tuberculosis in patients who tested negative for latent tuberculosis
infection prior to initiating therapy.
MALIGNANCIES
Lymphoma and other malignancies, some fatal, have been reported in children
and adolescent patients treated with TNF blockers, including Enbrel.

DRUG DESCRIPTION



What are the possible side effects of etanercept (Enbrel, Enbrel SureClick)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Serious and sometimes fatal infections may occur during treatment with etanercept. Stop using etanercept and call your doctor right away if you have signs of infection such as:

fever, sweating, chills, tired feeling;
feeling short of breath;
cough, sore throat; or
flu symptoms,...
Read All Potential Side Effects for Enbrel »




Enbrel (etanercept) is a dimeric fusion protein consisting of the extracellular
ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor
receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of
etanercept contains the CH2 domain, the CH3 domain and
hinge region, but not the CH1 domain of IgG1. Etanercept is produced
by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell
expression system. It consists of 934 amino acids and has an apparent molecular
weight of approximately 150 kilodaltons.
The solution of Enbrel in the single-use prefilled syringe and the single-use
prefilled SureClick autoinjector is clear and colorless, sterile, preservative-free,
and is formulated at pH 6.3 ± 0.2.
Enbrel is also supplied in a multiple-use vial as a sterile, white, preservative-free,
lyophilized powder. Reconstitution with 1 mL of the supplied Sterile Bacteriostatic
Water for Injection, USP (containing 0.9% benzyl alcohol) yields a multiple-use,
clear, and colorless solution with a pH of 7.4 ± 0.3.
Table 5: Contents of Enbrel



Presentation
Active Ingredient Content
Inactive Ingredients Content


Enbrel 50 mg prefilled syringe and SureClick autoinjector
0.98 mL of a 50 mg/mL solution of etanercept

1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate



Enbrel 25 mg prefilled syringe
0.51 mL of a 50 mg/mL solution of etanercept
1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate


Enbrel 25 mg multiple-usevial
25 mg etanercept
40 mg mannitol
10 mg sucrose
1.2 mg tromethamine



Last reviewed on RxList: 8/30/2010




Enbrel Drug Description
Enbrel
(etanercept) Solution for Subcutaneous Use

WARNINGS
SERIOUS INFECTIONS AND MALIGNANCIES
SERIOUS INFECTIONS
Patients treated with Enbrel are at increased risk for developing serious infections
that may lead to hospitalization or death [see WARNINGS AND PRECAUTIONS and
ADVERSE REACTIONS]. Most patients who developed these infections were taking
concomitant immunosuppressants such as methotrexate or corticosteroids.
Enbrel should be discontinued if a patient develops a serious infection or
sepsis.
Reported infections include:

Active tuberculosis, including reactivation of latent tuberculosis. Patients
with tuberculosis have frequently presented with disseminated or extrapulmonary
disease. Patients should be tested for latent tuberculosis before Enbrel use
and during therapy. Treatment for latent infection should be initiated prior
to Enbrel use.
Invasive fungal infections, including histoplasmosis, coccidioidomycosis,
candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with
histoplasmosis or other invasive fungal infections may present with disseminated,
rather than localized, disease. Antigen and antibody testing for histoplasmosis
may be negative in some patients with active infection. Empiric anti-fungal
therapy should be considered in patients at risk for invasive fungal infections
who develop severe systemic illness.
Bacterial, viral, and other infections due to opportunistic pathogens.

The risks and benefits of treatment with Enbrel should be carefully considered
prior to initiating therapy in patients with chronic or recurrent infection.
Patients should be closely monitored for the development of signs and symptoms
of infection during and after treatment with Enbrel, including the possible
development of tuberculosis in patients who tested negative for latent tuberculosis
infection prior to initiating therapy.
MALIGNANCIES
Lymphoma and other malignancies, some fatal, have been reported in children
and adolescent patients treated with TNF blockers, including Enbrel.

DRUG DESCRIPTION



What are the possible side effects of etanercept (Enbrel, Enbrel SureClick)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Serious and sometimes fatal infections may occur during treatment with etanercept. Stop using etanercept and call your doctor right away if you have signs of infection such as:

fever, sweating, chills, tired feeling;
feeling short of breath;
cough, sore throat; or
flu symptoms,...
Read All Potential Side Effects for Enbrel »




Enbrel (etanercept) is a dimeric fusion protein consisting of the extracellular
ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor
receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of
etanercept contains the CH2 domain, the CH3 domain and
hinge region, but not the CH1 domain of IgG1. Etanercept is produced
by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell
expression system. It consists of 934 amino acids and has an apparent molecular
weight of approximately 150 kilodaltons.
The solution of Enbrel in the single-use prefilled syringe and the single-use
prefilled SureClick autoinjector is clear and colorless, sterile, preservative-free,
and is formulated at pH 6.3 ± 0.2.
Enbrel is also supplied in a multiple-use vial as a sterile, white, preservative-free,
lyophilized powder. Reconstitution with 1 mL of the supplied Sterile Bacteriostatic
Water for Injection, USP (containing 0.9% benzyl alcohol) yields a multiple-use,
clear, and colorless solution with a pH of 7.4 ± 0.3.
Table 5: Contents of Enbrel



Presentation
Active Ingredient Content
Inactive Ingredients Content


Enbrel 50 mg prefilled syringe and SureClick autoinjector
0.98 mL of a 50 mg/mL solution of etanercept

1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate



Enbrel 25 mg prefilled syringe
0.51 mL of a 50 mg/mL solution of etanercept
1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate


Enbrel 25 mg multiple-usevial
25 mg etanercept
40 mg mannitol
10 mg sucrose
1.2 mg tromethamine



Last reviewed on RxList: 8/30/2010




Enbrel Drug Description
Enbrel
(etanercept) Solution for Subcutaneous Use

WARNINGS
SERIOUS INFECTIONS AND MALIGNANCIES
SERIOUS INFECTIONS
Patients treated with Enbrel are at increased risk for developing serious infections
that may lead to hospitalization or death [see WARNINGS AND PRECAUTIONS and
ADVERSE REACTIONS]. Most patients who developed these infections were taking
concomitant immunosuppressants such as methotrexate or corticosteroids.
Enbrel should be discontinued if a patient develops a serious infection or
sepsis.
Reported infections include:

Active tuberculosis, including reactivation of latent tuberculosis. Patients
with tuberculosis have frequently presented with disseminated or extrapulmonary
disease. Patients should be tested for latent tuberculosis before Enbrel use
and during therapy. Treatment for latent infection should be initiated prior
to Enbrel use.
Invasive fungal infections, including histoplasmosis, coccidioidomycosis,
candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with
histoplasmosis or other invasive fungal infections may present with disseminated,
rather than localized, disease. Antigen and antibody testing for histoplasmosis
may be negative in some patients with active infection. Empiric anti-fungal
therapy should be considered in patients at risk for invasive fungal infections
who develop severe systemic illness.
Bacterial, viral, and other infections due to opportunistic pathogens.

The risks and benefits of treatment with Enbrel should be carefully considered
prior to initiating therapy in patients with chronic or recurrent infection.
Patients should be closely monitored for the development of signs and symptoms
of infection during and after treatment with Enbrel, including the possible
development of tuberculosis in patients who tested negative for latent tuberculosis
infection prior to initiating therapy.
MALIGNANCIES
Lymphoma and other malignancies, some fatal, have been reported in children
and adolescent patients treated with TNF blockers, including Enbrel.

DRUG DESCRIPTION



What are the possible side effects of etanercept (Enbrel, Enbrel SureClick)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Serious and sometimes fatal infections may occur during treatment with etanercept. Stop using etanercept and call your doctor right away if you have signs of infection such as:

fever, sweating, chills, tired feeling;
feeling short of breath;
cough, sore throat; or
flu symptoms,...
Read All Potential Side Effects for Enbrel »




Enbrel (etanercept) is a dimeric fusion protein consisting of the extracellular
ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor
receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of
etanercept contains the CH2 domain, the CH3 domain and
hinge region, but not the CH1 domain of IgG1. Etanercept is produced
by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell
expression system. It consists of 934 amino acids and has an apparent molecular
weight of approximately 150 kilodaltons.
The solution of Enbrel in the single-use prefilled syringe and the single-use
prefilled SureClick autoinjector is clear and colorless, sterile, preservative-free,
and is formulated at pH 6.3 ± 0.2.
Enbrel is also supplied in a multiple-use vial as a sterile, white, preservative-free,
lyophilized powder. Reconstitution with 1 mL of the supplied Sterile Bacteriostatic
Water for Injection, USP (containing 0.9% benzyl alcohol) yields a multiple-use,
clear, and colorless solution with a pH of 7.4 ± 0.3.
Table 5: Contents of Enbrel



Presentation
Active Ingredient Content
Inactive Ingredients Content


Enbrel 50 mg prefilled syringe and SureClick autoinjector
0.98 mL of a 50 mg/mL solution of etanercept

1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate



Enbrel 25 mg prefilled syringe
0.51 mL of a 50 mg/mL solution of etanercept
1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate


Enbrel 25 mg multiple-usevial
25 mg etanercept
40 mg mannitol
10 mg sucrose
1.2 mg tromethamine



Last reviewed on RxList: 8/30/2010




Enbrel Drug Description
Enbrel
(etanercept) Solution for Subcutaneous Use

WARNINGS
SERIOUS INFECTIONS AND MALIGNANCIES
SERIOUS INFECTIONS
Patients treated with Enbrel are at increased risk for developing serious infections
that may lead to hospitalization or death [see WARNINGS AND PRECAUTIONS and
ADVERSE REACTIONS]. Most patients who developed these infections were taking
concomitant immunosuppressants such as methotrexate or corticosteroids.
Enbrel should be discontinued if a patient develops a serious infection or
sepsis.
Reported infections include:

Active tuberculosis, including reactivation of latent tuberculosis. Patients
with tuberculosis have frequently presented with disseminated or extrapulmonary
disease. Patients should be tested for latent tuberculosis before Enbrel use
and during therapy. Treatment for latent infection should be initiated prior
to Enbrel use.
Invasive fungal infections, including histoplasmosis, coccidioidomycosis,
candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with
histoplasmosis or other invasive fungal infections may present with disseminated,
rather than localized, disease. Antigen and antibody testing for histoplasmosis
may be negative in some patients with active infection. Empiric anti-fungal
therapy should be considered in patients at risk for invasive fungal infections
who develop severe systemic illness.
Bacterial, viral, and other infections due to opportunistic pathogens.

The risks and benefits of treatment with Enbrel should be carefully considered
prior to initiating therapy in patients with chronic or recurrent infection.
Patients should be closely monitored for the development of signs and symptoms
of infection during and after treatment with Enbrel, including the possible
development of tuberculosis in patients who tested negative for latent tuberculosis
infection prior to initiating therapy.
MALIGNANCIES
Lymphoma and other malignancies, some fatal, have been reported in children
and adolescent patients treated with TNF blockers, including Enbrel.

DRUG DESCRIPTION



What are the possible side effects of etanercept (Enbrel, Enbrel SureClick)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Serious and sometimes fatal infections may occur during treatment with etanercept. Stop using etanercept and call your doctor right away if you have signs of infection such as:

fever, sweating, chills, tired feeling;
feeling short of breath;
cough, sore throat; or
flu symptoms,...
Read All Potential Side Effects for Enbrel »




Enbrel (etanercept) is a dimeric fusion protein consisting of the extracellular
ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor
receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of
etanercept contains the CH2 domain, the CH3 domain and
hinge region, but not the CH1 domain of IgG1. Etanercept is produced
by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell
expression system. It consists of 934 amino acids and has an apparent molecular
weight of approximately 150 kilodaltons.
The solution of Enbrel in the single-use prefilled syringe and the single-use
prefilled SureClick autoinjector is clear and colorless, sterile, preservative-free,
and is formulated at pH 6.3 ± 0.2.
Enbrel is also supplied in a multiple-use vial as a sterile, white, preservative-free,
lyophilized powder. Reconstitution with 1 mL of the supplied Sterile Bacteriostatic
Water for Injection, USP (containing 0.9% benzyl alcohol) yields a multiple-use,
clear, and colorless solution with a pH of 7.4 ± 0.3.
Table 5: Contents of Enbrel



Presentation
Active Ingredient Content
Inactive Ingredients Content


Enbrel 50 mg prefilled syringe and SureClick autoinjector
0.98 mL of a 50 mg/mL solution of etanercept

1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate



Enbrel 25 mg prefilled syringe
0.51 mL of a 50 mg/mL solution of etanercept
1% sucrose
100 mM sodium chloride
25 mM L-arginine hydrochloride
25 mM sodium phosphate


Enbrel 25 mg multiple-usevial
25 mg etanercept
40 mg mannitol
10 mg sucrose
1.2 mg tromethamine



Last reviewed on RxList: 8/30/2010





Other reviews about Etanercept on wordpress

Reversal of Alzheimer's disease following perispinal etanercept administration
  by healthspanlife
Reversal of Alzheimer's disease following perispinal etanercept administration this work of the past 5 years from Los Angeles beggars belief, that any drug promoting neurotransmission via inhibition of […]


Perispinal Etanercept: Potential as an Alzheimer therapeutic
  by ktmoze
I recently viewed a video that an Alzheimer's patient has made extraordinary improvements in his cognitive skills and gait. You can view the video on www.alzheimersgroup.org. […]


Etanercept drug reverses early symptoms of Alzheimer's in 10 minutes
  by ktmoze
Scientists in the U.S. say a drug which can reverse some of the early symptoms of Alzheimer's disease takes effect within 10 minutes. The scientists from the University of […]


Does Etanercept (Enbrel) Work on Alzheimer's Patients?
  by BobDeMarco
A study reported in the journal BioMed Central BMC Neurology showed that 12 patients improved language recall shortly after treatment with Enbrel, or etanercept, a rheumatoid arthritis […]


Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease
  by Callier Library
from BMC Neurology Background Recent clinical studies point to rapid and sustained clinical, cognitive, and behavioral improvement in both Alzheimer's disease and primary progressive aphasia following weekly perispinal administration of […]


Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease
  by Callier Library
from BMC Neurology Background Recent clinical studies point to rapid and sustained clinical, cognitive, and behavioral improvement in both Alzheimer's disease and primary progressive aphasia following weekly perispinal administration of […]


Rapid Improvement Etanercept in Action
  by BobDeMarco
I finally found a website that has a great demonstration of Etanercept in action. The site is called Medscape. It does require a registration. However, the process is […]


UPDATE: DOES INTRASPINAL ETANERCEPT REVERSE ALZHEIMER'S DISEASE
  by healthspanlife
Regrettably, there is as yet apparently┬á no objective group clinical follow-up from Dr Tobinick or other clinicians since┬á this column's first report of February 2008 of instantaneous and […]


Association of Etanercept [Enbrel] with Histoplasmosis and Other Invasive Fungal Infections
  by thassodotcom
April 21, 2009 - Endorsed by Health Canada, Amgen Canada informed the Canadian public of important updated safety information regarding Etanercept [Enbrel]. Thus, Amgen Canada alerted the public to […]


Risk of serious fungal infections with Golimumab [Simponi]
  by thassodotcom
May 31, 2009 - In a safety information to rheumatological healthcare professionals, posted May 27, 2009, FDA and Centocor Ortho Biotech remind healthcare professionals of the risk of […]



Other reviews about Etanercept on web:

Etanercept (trade name Enbrel) is a drug that treats autoimmune diseases by interfering with the tumor necrosis factor (TNF, a part of the immune system) by acting as a TNF inhibitor. Etanercept - Wikipedia, the free encyclopedia


Details the medication etanercept (Enbrel) a drug used for treating rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Article includes descriptions, uses, drug ... etanercept (Enbrel) - drug class, medical uses, medication side ...


Enbrel (R) (etanercept) is treatment indicated for moderate to severe plaque psoriasis, psoriatic arthritis, and moderate to severe rheumatoid arthritis. Plaque Psoriasis and Rheumatoid Arthritis Treatment - Enbrel ...


All about Etanercept. View complete and up to date Etanercept information - part of the Drugs.com trusted medication database. Etanercept Facts and Comparisons at Drugs.com


Etanercept Brand names: Enbrel® Drug Forms: Etanercept injection (below) Etanercept Solution for injection Español: Inyección de etanercept Etanercept: Information from Answers.com


Etanercept is a prescription medicine used to treat inflammatory conditions like rheumatoid arthritis. This eMedTV page explains how the medication works, lists side effects, and ... Etanercept


Learn about the prescription medication Enbrel (Etanercept), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Enbrel (Etanercept) Drug Information: Uses, Side Effects, Drug ...


Comprehensive and trusted information about Etanercept - plus advice on 24,000 other FDA approved drugs and medications from Drugs.com. Etanercept patient advice including side effects


Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK: A comparison of etanercept ... Arthritis Research & Therapy | Full text | Do anti-TNF agents have ...


Learn more about Etanercept. Find the Web's best health guides, medical reports, news, videos and tools for Etanercept. Share Etanercept experiences and get advice from experts. Etanercept Overview - References, Advice, News, Videos, Coping ...





Featured Reviews

Reviews Trasylol

Trasylol Drug Description TRASYLOL® (aprotinin injection) Trasylol® administration may cause fatal anaphylactic or anaphylactoid reactions. Fatal reactions have occurred with an initial (test) dose as well as with any of the...
Read More  |  Review This
Reviews Synthetic conjugated estrogens

Cenestin Drug Description Cenestin® (synthetic conjugated estrogens, A) Tablets ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures,...
Read More  |  Review This
Reviews Americaine

Americaine Drug Description Americaine® Anesthetic Lubricant (benzocaine) DRUG DESCRIPTION What are the possible side effects of benzocaine topical? Get emergency medical help if you have any of these signs of an allergic...
Read More  |  Review This
Reviews Thioguanine

Tabloid Drug Description TABLOID® (thioguanine 40-mg) Scored Tablets CAUTION TABLOID brand Thioguanine is a potent drug. It should not be used unless a diagnosis of acute nonlymphocytic leukemia has been adequately established...
Read More  |  Review This
Reviews Ranexa

Ranexa Drug Description Ranexa (ranolazine) Extended-Release Tablets DRUG DESCRIPTION What are the possible side effects of ranolazine (Ranexa)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....